[1]胡宇才,董 倩,秦元梅,等.冠心丹参滴丸治疗冠心病心绞痛疗效与安全性系统评价[J].陕西中医,2021,(1):124-130.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.035]
　HU Yucai,DONG Qian,QIN Yuanmei,et al.Effectiveness and safety of Guanxin Danshen dropping pills in the treatment of angina pectoris of coronary atherosclerotic heart disease:a systematic review of randomized controlled trials[J].,2021,(1):124-130.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.035]
点击复制

冠心丹参滴丸治疗冠心病心绞痛疗效与安全性系统评价
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年1期
页码:
124-130
栏目:
Meta分析
出版日期:
2021-01-05

文章信息/Info

Title:
Effectiveness and safety of Guanxin Danshen dropping pills in the treatment of angina pectoris of coronary atherosclerotic heart disease:a systematic review of randomized controlled trials
作者:
胡宇才1; 董 倩2; 秦元梅2 ; 彭广操1
(1.河南中医药大学第一附属医院,河南 郑州 450000; 2.河南中医药大学,河南 郑州 450046)
Author(s):
HU Yucai; DONG Qian; QIN Yuanmei; PENG Guangcao
(The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450000,China)
关键词:
丹参滴丸;  冠心病心绞痛;  系统评价
Keywords:
Guanxin Danshen drop pill;  Angina pectoris of coronary atherosclerotic heart disease;  Systematic review
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7369.2020.01.035
文献标志码:
A
摘要:
目的:系统评价冠心丹参滴丸治疗冠心病心绞痛的疗效与安全性。方法:计算机检索自建库至2019年10月CNKI-WanFang-VIP-SinoMed-PubMed-Web of Science-Cochrane Library数据库,搜索并筛选符合纳入标准的冠心丹参滴丸治疗冠心病心绞痛的随机对照试验。按Cochrane手册5.1.0推荐的质量评价标准对纳入研究的RCT文献进行偏倚分析,采用RevMan 5.3软件进行Meta分析。结果:共纳入24篇文献,Meta分析结果显示:冠心丹参滴丸与西药联合应用较单纯西药治疗在心绞痛症状改善方面疗效较好[(RR=1.20,95%CI:(1.10,1.30),Z=4.18,P<0.0001)]; 冠心丹参滴丸可有效改善患者心电图疗效(RR=1.27,95%CI:[1.19,1.34],Z=7.60,P<0.00001),降低心绞痛发作频率(WMD=-0.93,95%CI:[-1.18,-0.69],Z=7.53,P<0.00001)。结论:冠心丹参滴丸治疗冠心病心绞痛有一定的疗效,其在血脂水平及血液流变学指标等方面也具有统计学意义,治疗效果明显优于单纯常规治疗或西医治疗。不良反应情况较为轻微,提示安全性较好,但受到纳入研究的质量影响,部分结局指标可能存在偏倚,因此,近一步证据仍有待高质量大样本随机对照试验提供。
Abstract:
Objective:To valuate the efficacy and safety of Guanxin Danshen dropping pills in the treatment of angina pectoris of coronary heart disease.Methods:The computer searched the CNKI、WanFang、VIP、SinoMed、PubMed、Web of Science、Cochrane Library database from the establishment of the database to October 2019,and searched and screened the randomized controlled trial of Guanxin Danshen dropping pills in the treatment of angina pectoris of coronary atherosclerotic heart disease.According to the quality evaluation standard recommended by Cochrane Manual 5.1.0,the RCT literature included in the study was biased and Meta was analyzed by RevMan 5.3 software.Results:A total of 24 articles were included.Meta-analysis showed that Guanxin Danshen dropping pills combined with western medicine was more effective in improving angina pectoris symptoms than western medicine alone(RR=1.20,95%CI: [1.10,1.30],Z=4.18,P<0.0001).Guanxin Danshen dropping pills can effectively improve the curative effect of electrocardiogram(RR=1.27,95%CI: [1.19,1.34],Z=7.60,P<0.00001),reduce the frequency of angina pectoris(WMD=-0.93,95%CI: [-1.18,-0.69],Z=7.53,P<0.00001).Conclusion:Guanxin Danshen dropping pills has certain curative effect on angina pectoris of coronary atherosclerotic heart disease and also have statistical significance in blood lipid level and hemorheological indexes,and the therapeutic effect is obviously better than that of routine treatment or western medicine alone.The adverse reactions were mild,suggesting that the safety was better.However,due to the influence of the quality of the study,some outcome indicators may be biased,so the further evidence still needs to be provided by high quality large sample randomized controlled trials.

参考文献/References:

[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] Ong P,Anastasios A,Udo S.Treatment of angina pectoris associated with coronary microvascular dysfunction[J].Cardiovascular Drugs and Therap,2016,30(4):351-356.
[3] 王 阶,陈 光.冠心病稳定型心绞痛中医诊疗专家共识[J].中医杂志,2018,59(5):447-450.
[4] 宋海英,刘剑刚,王培利,等.冠心丹参滴丸药理作用及临床应用研究进展[J].中药新药与临床药理,2018,29(2):247-250.
[5] 李春兰.冠心丹参滴丸与单硝酸异山梨酯联用治疗冠心病心绞痛的疗效观察[J].医药前沿,2012,2(5):24.
[6] 李世林.中西药联合治疗冠心病心绞痛临床观察[J].医药论坛杂志,2008,29(3):77-79.
[7] 李欣鑫.丹参不同给药方式对冠心病不稳定型心绞痛的影响[J].湖南中医药大学学报,2013,33(4):12-13.
[8] 彭岳珍.联合应用冠心丹参滴丸与单硝酸异山梨酯治疗心绞痛68例临床疗效观察[J].大家健康:上旬版,2016,10(5):142-143.
[9] 谢 欣.对比分析复方丹参片与冠心丹参滴丸在治疗冠心病心绞痛方面的临床疗效[J].中外健康文摘,2012,9(23):266-267.
[10] 赵 敏,袁宇红.冠心丹参滴丸对冠心病心绞痛血浆内皮素及一氧化氮水平的影响[J].中医药学刊,2002,20(9):99,108-109,136.
[11] 李加栋,韩琳琳,朱月霞,等.冠心丹参滴丸治疗冠心病稳定性心绞痛200例[J].中外医疗,2017,36(24):126-128.
[12] 吕 朗,王 涛,陈永清.冠心丹参滴丸治疗冠心病稳定性心绞痛109例[J].河南中医,2016,36(2):240-241.
[13] 张丹丹,韩安邦,武 婧,等.冠心丹参滴丸对冠心病稳定性心绞痛血瘀证患者炎症因子干预作用的研究[J].世界中西医结合杂志,2018,13(4):509-513.
[14] 高宏敏.冠心丹参滴丸联合西药对冠心病心绞痛患者血脂影响及疗效观察[J].中国民间疗法,2016,24(5):65-66.
[15] 史鹏翔.冠心丹参滴丸治疗不稳定型心绞痛的临床疗效观察[J].临床合理用药杂志,2014,7(12):112-113.
[16] 尹 琼,谢中华.冠心丹参滴丸配合消心痛治疗冠心病心绞痛70例疗效观察[J].中国现代药物应用,2012,6(19):59-60.
[17] 邢存才.冠心丹参滴丸联合西药治疗不稳定性心绞痛随机对照研究[J].实用中医内科杂志,2012,26(8):32-33.
[18] 谢 磊.氯吡格雷联合冠心丹参滴丸治疗不稳定型心绞痛临床观察[J].基层医学论坛,2014,18(16):2099-2100.
[19] 张 青.冠心丹参滴丸治疗冠心病心绞痛疗效观察[J].中外医疗,2012,31(15):103-104.
[20] 谭 劼,郭永谊,张红雨.冠心丹参滴丸治疗冠心病心绞痛临床观察[J].中国中医急症,2010,19(11):1836-1837.
[21] 杨 靖,夏 阳.冠心丹参滴丸治疗冠心病及其危险因素研究[J].实用心脑肺血管病杂志,2012,20(7):1100-1102.
[22] 张黎歌,刘玉华,朱 杰,等.冠心丹参滴丸对改善老年性冠心病心绞痛的临床研究[J].中国社区医师:综合版,2006(2):61-62.
[23] 张 瑛.冠心丹参滴丸治疗冠心病心绞痛疗效观察[J].吉林中医药,2008,30(10):722.
[24] 陈智龙,刘 莉,毕朝芳.冠心丹参滴丸治疗老年稳定型心绞痛疗效观察[J].湖北中医杂志,2009,31(10):33.
[25] 陈 燕.冠心丹参滴丸治疗稳定型劳力性心绞痛50例[J].中西医结合心脑血管病杂志,2006(10):906-907.
[26] 鄂璐莎.冠心丹参滴丸联合辛伐他汀片治疗冠心病的临床研究[J].中国临床药理学杂志,2018,34(19):2252-2255.
[27] 高红燕.冠心丹参滴丸与复方丹参片治疗冠心病心绞痛疗效比较[J].临床合理用药杂志,2012,5(2):9-10.
[28] 李 莉.冠心丹参滴丸联合辛伐他汀治疗冠心病心绞痛疗效及对血脂和血液流变学的影响[J].中国中医基础医学杂志,2013,19(10):1149-1150.
[29] Liu SH,Chuang WC,Lam W,et al.Safety surveillance of traditional Chinese medicine:current and future[J].Drug Saf,2015,38(2):117-128.
[30] 罗 镭.冠心丹参滴丸质量标准的研究[J].海峡药学,2017,29(6):52-54.
[31] 武 婧,张丹丹,王倩文,等.冠心丹参滴丸治疗冠心病心绞痛及焦虑抑郁状态的临床研究[J].中西医结合心脑血管病杂志,2017,15(13):1609-1612.

相似文献/References:

[1]陈曼丽,宫 蕊,齐莉莉,等.丹红注射液联合麝香保心丸治疗冠心病心绞痛疗效及对患者NF-κB、GMP-140的影响*[J].陕西中医,2020,(3):321.
[2]冯 娟,闫奎坡,朱明军,等.瓜蒌薤白半夏汤联合血府逐瘀汤从痰瘀论治冠心病心绞痛疗效Meta分析[J].陕西中医,2021,(3):393.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.033]

备注/Memo

备注/Memo:
基金项目:国家中医药管理局中医药循证能力建设项目(2019XZZX-XXG003); 河南省高等学校重点科研项目(19A320023); 河南省中医管理局国家中医临床研究基地科研专项(2017JDZX036)
更新日期/Last Update: 2021-01-11